EMJ GOLD - European Medical Journal

This site is intended for healthcare professionals

Continue

Pharma News, Views & Analysis

Filter Advertise With Us
People shaking hands on a merger

Pfizer enters obesity race with $4.9bn Metsera deal

Pfizer is claiming a space in the global obesity market as it announces plans to acquire weight loss drug developer Metsera for $4.9bn.
An illustration of two people's hands shaking, wearing suits

Roche acquires US biotech 89bio for $3.5bn

Roche acquires 89bio in a $3.5bn deal, adding a late-stage MASH therapy and expanding its focus on cardiovascular and metabolic diseases.
Person typing on computer

New study reveals risks of patients using ChatGPT

Patients are increasingly turning to ChatGPT for medical advice, but new research warns it isn’t yet accurate enough to be relied on alone.
Magnifying glass on upward trajectory

GLP-1 therapies in trials for 100+ diseases, Phesi finds

Phesi analysis shows GLP-1 therapies moving beyond diabetes and obesity into 100+ diseases, from cancer to cardiovascular conditions.
Coins falling

ABPI report highlights decline in UK pharma investment

The latest ABPI and PwC Pharmaceutical Competitiveness Framework reveals the UK is losing ground in pharma R&D, investment, and clinical trials, with rankings slipping sharply since 2018.

Novo Nordisk cuts jobs to fund diabetes and obesity growth

Novo Nordisk announces 9,000 job cuts to streamline operations and reinvest in diabetes and obesity growth, aiming for long-term efficiency.

Lilly's TuneLab to share AI models with small biotechs

Lilly has launched TuneLab, giving biotech companies access to AI-powered drug discovery models based on over £1bn in research investment.

MSD strikes $10bn deal for Verona Pharma

MSD has agreed to acquire UK biopharma company Verona Pharma in a $10bn deal, strengthening its cardio-pulmonary care portfolio.
We’ve noticed you’re accessing
from North/South America.